US Stock MarketDetailed Quotes

SNOA Sonoma Pharmaceuticals

Watchlist
  • 2.4876
  • -0.1324-5.05%
Close Feb 14 16:00 ET
  • 2.5000
  • +0.0124+0.50%
Post 20:01 ET
4.02MMarket Cap-1.10P/E (TTM)

Sonoma Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Dec 31, 2024
(Q2)Sep 30, 2024
(Q1)Jun 30, 2024
(FY)Mar 31, 2024
(Q4)Mar 31, 2024
(Q3)Dec 31, 2023
(Q2)Sep 30, 2023
(Q1)Jun 30, 2023
(FY)Mar 31, 2023
(Q4)Mar 31, 2023
Total revenue
13.58%3.56M
31.05%3.58M
-1.05%3.39M
-4.05%12.74M
14.10%3.44M
6.59%3.14M
-18.01%2.73M
-13.96%3.43M
5.10%13.27M
31.16%3.01M
Operating revenue
13.58%3.56M
31.05%3.58M
-1.05%3.39M
-4.05%12.74M
14.10%3.44M
6.59%3.14M
-18.01%2.73M
-13.96%3.43M
5.10%13.27M
31.16%3.01M
Cost of revenue
36.71%2.29M
27.40%2.22M
-6.21%2.09M
-9.15%7.99M
9.21%2.35M
-20.59%1.68M
-3.01%1.74M
-4.88%2.22M
1.85%8.8M
-2.36%2.15M
Gross profit
-13.01%1.27M
37.47%1.36M
8.47%1.31M
5.99%4.75M
26.27%1.09M
75.69%1.46M
-35.55%990K
-26.85%1.2M
12.12%4.48M
800.00%864K
Operating expense
-0.13%2.3M
0.59%2.21M
1.43%2.48M
4.41%9.45M
24.32%2.5M
-13.55%2.3M
-3.04%2.2M
-2.28%2.44M
-8.43%9.05M
-36.28%2.01M
Selling and administrative expenses
10.04%1.87M
2.59%1.71M
-5.19%2.01M
-14.31%7.58M
15.52%2.09M
-36.10%1.7M
-19.59%1.66M
-7.67%2.12M
-9.38%8.84M
-42.58%1.81M
Research and development costs
-28.95%427K
-5.60%506K
44.62%470K
803.86%1.87M
103.48%409K
--601K
168.00%536K
57.77%325K
65.60%207K
4,925.00%201K
Operating profit
-22.16%-1.03M
29.64%-850K
5.40%-1.17M
-2.87%-4.7M
-22.84%-1.41M
53.98%-844K
-65.25%-1.21M
-45.03%-1.24M
22.37%-4.57M
62.52%-1.15M
Net non-operating interest income expense
Other net income (expense)
241.77%112K
530.00%387K
183.41%176K
46.25%-330K
117.12%50K
-11.27%-79K
51.61%-90K
-214.93%-211K
-228.18%-614K
-37.09%-292K
Other non- operating income (expenses)
241.77%112K
530.00%387K
183.41%176K
46.25%-330K
117.12%50K
-11.27%-79K
51.61%-90K
-214.93%-211K
-55.84%-614K
68.80%-292K
Income before tax
0.43%-919K
64.33%-463K
31.29%-997K
2.95%-5.03M
5.56%-1.36M
51.55%-923K
-41.55%-1.3M
-57.38%-1.45M
4.32%-5.18M
56.15%-1.44M
Income tax
115.79%9K
-20.97%147K
542.42%146K
-493.94%-196K
-122.90%-292K
-267.65%-57K
86.00%186K
5.71%-33K
90.06%-33K
61.24%-131K
Net income
-7.16%-928K
58.89%-610K
19.39%-1.14M
6.13%-4.84M
18.43%-1.07M
55.34%-866K
-45.92%-1.48M
-59.86%-1.42M
-1.28%-5.15M
55.57%-1.31M
Net income continuous Operations
-7.16%-928K
58.89%-610K
19.39%-1.14M
6.13%-4.84M
18.43%-1.07M
55.34%-866K
-45.92%-1.48M
-59.86%-1.42M
-1.28%-5.15M
55.57%-1.31M
Minority interest income
Net income attributable to the parent company
-7.16%-928K
58.89%-610K
19.39%-1.14M
6.13%-4.84M
18.43%-1.07M
55.34%-866K
-45.92%-1.48M
-59.86%-1.42M
-1.28%-5.15M
55.57%-1.31M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-7.16%-928K
58.89%-610K
19.39%-1.14M
6.13%-4.84M
18.43%-1.07M
55.34%-866K
-45.92%-1.48M
-59.86%-1.42M
-1.28%-5.15M
55.57%-1.31M
Basic earnings per share
60.38%-0.63
89.74%-0.59
75.86%-1.4
65.13%-10.6
75.58%-1.3673
87.18%-1.59
12.88%-5.75
0.00%-5.8
20.83%-30.4
73.83%-5.6
Diluted earnings per share
60.38%-0.63
89.74%-0.59
75.86%-1.4
65.13%-10.6
75.58%-1.3673
87.18%-1.59
12.88%-5.75
0.00%-5.8
20.83%-30.4
73.83%-5.6
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Dec 31, 2024(Q2)Sep 30, 2024(Q1)Jun 30, 2024(FY)Mar 31, 2024(Q4)Mar 31, 2024(Q3)Dec 31, 2023(Q2)Sep 30, 2023(Q1)Jun 30, 2023(FY)Mar 31, 2023(Q4)Mar 31, 2023
Total revenue 13.58%3.56M31.05%3.58M-1.05%3.39M-4.05%12.74M14.10%3.44M6.59%3.14M-18.01%2.73M-13.96%3.43M5.10%13.27M31.16%3.01M
Operating revenue 13.58%3.56M31.05%3.58M-1.05%3.39M-4.05%12.74M14.10%3.44M6.59%3.14M-18.01%2.73M-13.96%3.43M5.10%13.27M31.16%3.01M
Cost of revenue 36.71%2.29M27.40%2.22M-6.21%2.09M-9.15%7.99M9.21%2.35M-20.59%1.68M-3.01%1.74M-4.88%2.22M1.85%8.8M-2.36%2.15M
Gross profit -13.01%1.27M37.47%1.36M8.47%1.31M5.99%4.75M26.27%1.09M75.69%1.46M-35.55%990K-26.85%1.2M12.12%4.48M800.00%864K
Operating expense -0.13%2.3M0.59%2.21M1.43%2.48M4.41%9.45M24.32%2.5M-13.55%2.3M-3.04%2.2M-2.28%2.44M-8.43%9.05M-36.28%2.01M
Selling and administrative expenses 10.04%1.87M2.59%1.71M-5.19%2.01M-14.31%7.58M15.52%2.09M-36.10%1.7M-19.59%1.66M-7.67%2.12M-9.38%8.84M-42.58%1.81M
Research and development costs -28.95%427K-5.60%506K44.62%470K803.86%1.87M103.48%409K--601K168.00%536K57.77%325K65.60%207K4,925.00%201K
Operating profit -22.16%-1.03M29.64%-850K5.40%-1.17M-2.87%-4.7M-22.84%-1.41M53.98%-844K-65.25%-1.21M-45.03%-1.24M22.37%-4.57M62.52%-1.15M
Net non-operating interest income expense
Other net income (expense) 241.77%112K530.00%387K183.41%176K46.25%-330K117.12%50K-11.27%-79K51.61%-90K-214.93%-211K-228.18%-614K-37.09%-292K
Other non- operating income (expenses) 241.77%112K530.00%387K183.41%176K46.25%-330K117.12%50K-11.27%-79K51.61%-90K-214.93%-211K-55.84%-614K68.80%-292K
Income before tax 0.43%-919K64.33%-463K31.29%-997K2.95%-5.03M5.56%-1.36M51.55%-923K-41.55%-1.3M-57.38%-1.45M4.32%-5.18M56.15%-1.44M
Income tax 115.79%9K-20.97%147K542.42%146K-493.94%-196K-122.90%-292K-267.65%-57K86.00%186K5.71%-33K90.06%-33K61.24%-131K
Net income -7.16%-928K58.89%-610K19.39%-1.14M6.13%-4.84M18.43%-1.07M55.34%-866K-45.92%-1.48M-59.86%-1.42M-1.28%-5.15M55.57%-1.31M
Net income continuous Operations -7.16%-928K58.89%-610K19.39%-1.14M6.13%-4.84M18.43%-1.07M55.34%-866K-45.92%-1.48M-59.86%-1.42M-1.28%-5.15M55.57%-1.31M
Minority interest income
Net income attributable to the parent company -7.16%-928K58.89%-610K19.39%-1.14M6.13%-4.84M18.43%-1.07M55.34%-866K-45.92%-1.48M-59.86%-1.42M-1.28%-5.15M55.57%-1.31M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -7.16%-928K58.89%-610K19.39%-1.14M6.13%-4.84M18.43%-1.07M55.34%-866K-45.92%-1.48M-59.86%-1.42M-1.28%-5.15M55.57%-1.31M
Basic earnings per share 60.38%-0.6389.74%-0.5975.86%-1.465.13%-10.675.58%-1.367387.18%-1.5912.88%-5.750.00%-5.820.83%-30.473.83%-5.6
Diluted earnings per share 60.38%-0.6389.74%-0.5975.86%-1.465.13%-10.675.58%-1.367387.18%-1.5912.88%-5.750.00%-5.820.83%-30.473.83%-5.6
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--
Trending Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Argo Blockchain
ARBK
+5.33%
BTCS Inc
BTCS
+3.20%
Canaan
CAN
+2.29%
Bit Origin
BTOG
+1.90%
Bitfarms
BITF
+1.43%

Unlock the Full List